Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Left Bundle Branch Area Pacing (LBBAP) PMCF Study

NCT: NCT07217392 · RECRUITING

NCT IDNCT07217392
StatusRECRUITING
Start Date2025-07-24
Completion2027-04-30

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6 months post-implant.

Frequently Asked Questions

What is Left Bundle Branch Area Pacing (LBBAP) PMCF Study?

Left Bundle Branch Area Pacing (LBBAP) PMCF Study is a clinical trial registered under NCT07217392. Current status: RECRUITING.

What is the status of NCT07217392?

The current status of NCT07217392 (Left Bundle Branch Area Pacing (LBBAP) PMCF Study) is: RECRUITING.

When did Left Bundle Branch Area Pacing (LBBAP) PMCF Study start?

Left Bundle Branch Area Pacing (LBBAP) PMCF Study started on 2025-07-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.